Confidential Treatment Sample Clauses

Confidential Treatment. The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.
Confidential Treatment. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Furthermore, except as required by law (including, but not limited to semi-annual, annual or other filings made under the 1940 Act) or as agreed to by the Adviser and Sub-Adviser, the Adviser and Trust will not disclose any list of securities held by the Fund until it is either filed with the Securities & Exchange Commission or mailed out to shareholders, which filing or mailing shall not be made sooner than 30 days after quarter end in any manner whatsoever except as expressly authorized in this Agreement, except that the top 10 holdings may be disclosed 15 days after month end. In addition, at the end of each quarter, the Adviser may disclose to certain third party data or service providers to the Fund, who have entered into a confidentiality agreement with the Adviser, a list of securities purchased or sold by the Fund during the quarter.
Confidential Treatment. All information and advice furnished by one party to the other party (including their respective agents, employees and representatives) hereunder shall be treated as confidential and shall not be disclosed to third parties, except as may be necessary to comply with applicable laws, rules and regulations, subpoenas or court orders. It is understood that any information or recommendation supplied by, or produced by, Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Adviser and the Trust. Without limiting the foregoing, the Adviser and the Trust will only disclose portfolio information in accordance with the Trust’s portfolio information policy as adopted by the Board of Trustees.
Confidential Treatment. Customer understands and agrees that the information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer agrees to limit the disclosure of its contents to employees of Customer with a need to know the contents for purposes of helping Customer perform its obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of Boeing. Very truly yours, THE BOEING COMPANY By /s/ Jeffery J. Solomon Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: September 18, 2012 AVOLON AEROSPACE LEASING LIMITED By /s/ Tom Ashe Its Director The Partial Assignment of Rights form which follows as Attachment A must be executed prior to the provision of the training, services and Materials described in the applicable Supplemental Exhibit (Customer Support Document) to the Purchase Agreement. It assigns only rights described in such document and does not assign warranty or other rights under the Purchase Agreement, which are reserved until delivery and are assigned at that time. The Boeing Company P.O. Box 3707 Seattle, WA 98124-2207 Boeing Commercial Airplanes P.O. Box 3707 Seattle, Washington 98124-2207 Attention: Vice PresidentContracts Mail Stop 75-38 Subject: Partial Assignment of Rights – Avolon Aerospace Leasing Limited as Lessor and as Lessee of Model 737-8 Aircraft Gentlemen: In connection with the lease by Avolon Aerospace Leasing Limited (Customer) to (Lessee) of a Boeing aircraft (more fully described below), reference is made to the following documents:
Confidential Treatment. Customer understands that certain commercial and financial information contained in this Letter Agreement, and any attachments hereto, is considered by Boeing as confidential. Buyer agrees that it will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of Boeing, disclose this Letter Agreement or any information contained herein to any other person or entity. Very truly yours, THE BOEING COMPANY By /s/ Dawn S. Foster ------------------------ Its Attorney-In-Fact ------------------------ ACCEPTED AND AGREED TO this Date: June 6, 1997 ATLAS AIR, INC. By /s/ M.A. Chowdry ------------------------ Its CEO ------------------------ [ ] (CALENDAR YEARS 1999 AND ON)
Confidential Treatment. Customer understands that certain commercial and financial information contained in this Letter Agreement are considered by Boeing as confidential. Customer agrees that it will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of Boeing, disclose this Letter Agreement or any information contained herein to any other person or entity except to potential Assignees that would qualify under paragraph 1.1 or unless required by law. Very truly yours, THE BOEING COMPANY By ----------------------------------- Its Attorney-In-Fact ----------------------------------- Midway Airlines Corporation 6-1162-CPJ-314 Page 2 ACCEPTED AND AGREED TO this Date:_______________________________ , 1999 Midway Airlines Corporation By___________________________________ Its__________________________________ ATTACHMENT A TO 6-1162-CPJ-314 [REDACTED] ---------- 6-1162-CPJ-315 Midway Airlines Corporation 2801 Slater Road, Suite 200 Morrisville, NC 27560 Subject: Miscellaneous Matters Reference: Purchase Agreement No. 2235 (the Purchase Agreement) between The Boeing Company (Boeing) and Midway Airlines Corporation (Customer) relating to Model 737-7BX aircraft (Aircraft) This Letter Agreement amends, supplements, and is part of the Purchase Agreement. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement.
Confidential Treatment. The information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Customer will limit the disclosure of its contents to employees of Customer with a need to know the contents for purposes of helping Customer perform its obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of Boeing. Very truly yours, THE BOEING COMPANY By Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: July 21, 2010 AMERICAN AIRLINES, INC. By Its P.A. No. 3219 SA-2 Performance Guarantee Matters Rev.: 04/03/08
Confidential Treatment. Buyer understands that certain commercial and financial information contained in this Letter Agreement are considered by Boeing as confidential. Buyer agrees that it will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of Boeing, disclose this Letter Agreement or any information contained herein to any other person or entity. Very truly yours, THE BOEING COMPANY By /s/ Kris A. Campbell Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: January 11, 2002 SOCIETE AIR FRANCE By /s/ Pierre VELLAY Its VP New Aircraft and Fleet Planning P.O. Box 3707 Seattle, WA 98124-2207 6-1163-STE-3507 societe Air France Roissypole 45 Rue de Paris 95747 Roissy Charles de Gaulle France Subject: [CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT] Reference: Purchase Agreement No. 1966 (the Purchase Agreement) between The Boeing Company (Boeing) and societe Air France (Buyer) relating to Model 777-300ER aircraft (the Aircraft) This Letter Agreement amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement have the same meaning as in the Purchase Agreement.
Confidential Treatment. The information contained herein represents confidential business information and has value precisely because it is not available generally or to other parties. Each party will limit the disclosure of its contents to its employees with a need to know the contents for purposes of helping it perform its obligations under the Purchase Agreement and who understand they are not to disclose its contents to any other person or entity without the prior written consent of the other party. Notwithstanding the foregoing, either party may disclose this Letter Agreement (i) for the purpose of regulatory requirements, including without limitation registrations and filings pursuant thereto, or as otherwise required by law, provided that the disclosing party makes commercially reasonable efforts to notify the non-disclosing party in advance of such disclosure and considers in good faith all limitations on such disclosure requested by [***] Confidential portion omitted and filed separately with the Commission Pursuant to a Request for Confidential Treatment. the non-disclosing party; (ii) for the purpose of disclosure to its auditors and its legal advisors on a need to know basis who themselves agree not to further disclose such information; and (iii) to the extent such information is publicly available other than as a result of the disclosure by or on behalf of such party. Very truly yours, THE BOEING COMPANY By /s/ Will Witherspoon Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: December 16, 2015 DELTA AIR LINES, INC. By /s/ Gregory A. May Its SVP - Supply Chain Management [***] Confidential portion omitted and filed separately with the Commission Pursuant to a Request for Confidential Treatment. [***] [***] Confidential portion omitted and filed separately with the Commission Pursuant to a Request for Confidential Treatment. DAL-PA-02022-LA-1105843R3 Delta Air Lines, Inc. PO Box 20706 Atlanta GA 30320-6001 Subject: [***] Reference: Purchase Agreement No. PA-02022 (Purchase Agreement) between The Boeing Company (Boeing) and Delta Air Lines, Inc. (Customer) relating to Model 737-900ER aircraft (Aircraft) This letter agreement (Letter Agreement) amends and supplements the Purchase Agreement. All terms used but not defined in this Letter Agreement shall have the same meaning as in the Purchase Agreement. This Letter Agreement has been revised to include the additional twenty (20) Incremental Aircraft identified in Supplemental Agreement No. 17 (SA-17). [***]
Confidential Treatment. Boeing and Customer understand that certain information contained in this Letter Agreement is considered to be confidential. The parties agree that they will treat this Letter Agreement and the information contained herein as confidential and will not, without the prior written consent of the other party, disclose this Letter Agreement or any information contained herein to any other person or entity except, (1) to those of their respective legal counsel, auditors, accountants, insurance brokers and other advisers who have a need to know the information for purposes of interpreting Customer’s rights or interpreting or performing Customer’s obligations under the Purchase Agreement, subject to such parties’ written agreements that they will treat the information as confidential, (2) to a bank for the sole purpose of financing of the purchase of such Aircraft and subject to such bank’s written agreement that it will treat the information as confidential, (3) as required by the rules of any stock market applicable to the parties on condition that the party wishing to make such disclosure shall first use reasonable efforts to seek relief from the risk of disclosure to competitors or others with whom either of the parties has business relations of information which might be detrimental to the interest of either of the parties, or (4) as may be required by applicable law. P.A. No. 3323 Xiamen Airlines 6-1165-CKR-1452 THE BOEING COMPANY By /s/ Christian K. Riddle Its Attorney-In-Fact ACCEPTED AND AGREED TO this Date: April 18, 2008 XIAMEN AIRLINES By /s/ Yang Guang Hua Its P.A. No. 3323 The Boeing Company P.O. Box 3707 Seattle, WA 98124-2207 6-1165-CKR-1454 Xiamen Airlines